These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21768699)

  • 1. Osteopontin expression in nasopharyngeal carcinoma: its relevance to the clinical stage of the disease.
    Wang HH; Wang XW; Tang CE
    J Cancer Res Ther; 2011; 7(2):138-42. PubMed ID: 21768699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of osteopontin promotes cell proliferation and migration in human nasopharyngeal carcinoma and is associated with poor prognosis.
    Qin H; Wang R; Wei G; Wang H; Pan G; Hu R; Wei Y; Tang R; Wang J
    Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):525-534. PubMed ID: 29214433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin promotes EZH2 expression and tumor progression in nasopharyngeal carcinoma.
    Ma R; Luo X; Feng S; Li J; Fan Y; Wen W; Li H
    ORL J Otorhinolaryngol Relat Spec; 2014; 76(5):273-81. PubMed ID: 25471249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin is a useful predictor of bone metastasis and survival in patients with locally advanced nasopharyngeal carcinoma.
    Hou X; Wu X; Huang P; Zhan J; Zhou T; Ma Y; Qin T; Luo R; Feng Y; Xu Y; Chen L; Zhang L
    Int J Cancer; 2015 Oct; 137(7):1672-8. PubMed ID: 25824984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin regulates growth and migration of human nasopharyngeal cancer cells.
    Yang G; Zhang Y; Wu J; Xiong J; Deng H; Wang J; Yang C; Zhu Z
    Mol Med Rep; 2011; 4(6):1169-73. PubMed ID: 21785824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway.
    Chen CH; Shiu LY; Su LJ; Huang CY; Huang SC; Huang CC; Yin YF; Wang WS; Tsai HT; Fang FM; Chuang WC; Kang HC; Hwang CF
    J Transl Med; 2012 May; 10():93. PubMed ID: 22591637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of plasma osteopontin level in patients with undifferentiated nasopharyngeal carcinoma.
    Wong TS; Kwong DL; Sham J; Wei WI; Kwong YL; Yuen AP
    Eur J Surg Oncol; 2005 Jun; 31(5):555-8. PubMed ID: 15922893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix Metalloproteinase 14 Overexpression Is Correlated with the Progression and Poor Prognosis of Nasopharyngeal Carcinoma.
    Yan TH; Lin ZH; Jiang JH; Lu SW; Que HX; Chen MA; He XS; Que GB; Xiao JN; Chen YQ
    Arch Med Res; 2015 Apr; 46(3):186-92. PubMed ID: 25829357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDK3 expression and its clinical significance in human nasopharyngeal carcinoma.
    Wang L; Hu HY; Lin YL; Zhao ZX; Tan L; Yu P; Wan HJ; Jin Z; Zheng D
    Mol Med Rep; 2014 Jun; 9(6):2582-6. PubMed ID: 24691537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of osteopontin polymorphisms with nasopharyngeal carcinoma risk.
    Wang J; Nong L; Wei Y; Qin S; Zhou Y; Tang Y
    Hum Immunol; 2014 Jan; 75(1):76-80. PubMed ID: 24120738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.
    Su Y; Yu QH; Wang XY; Yu LP; Wang ZF; Cao YC; Li JD
    BMC Cancer; 2017 Jul; 17(1):477. PubMed ID: 28693517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of osteopontin expression in human gastric carcinoma.
    Higashiyama M; Ito T; Tanaka E; Shimada Y
    Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression level of NUAK1 in human nasopharyngeal carcinoma and its prognostic significance.
    Liu J; Tang G; Huang H; Li H; Zhang P; Xu L
    Eur Arch Otorhinolaryngol; 2018 Oct; 275(10):2563-2573. PubMed ID: 30121842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of integrin αv in the human nasopharyngeal carcinoma associated with metastasis and progression.
    Xuan SH; Zhou YG; Pan JQ; Zhu W; Xu P
    Cancer Biomark; 2013; 13(5):323-8. PubMed ID: 24440971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes.
    Yang Q; Lin H; Wu S; Lei F; Zhu X; Song L; Hong M; Guo L
    PLoS One; 2015; 10(8):e0136448. PubMed ID: 26305455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and clinical significance of cyclin E2 in nasopharyngeal carcinoma].
    Zhao GH; Xie GQ; Miao YY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):291-3. PubMed ID: 22394640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of cytoplasmic KLF4 expression is correlated with the progression and poor prognosis of nasopharyngeal carcinoma.
    Liu Z; Yang H; Luo W; Jiang Q; Mai C; Chen Y; Zhen Y; Yu X; Long X; Fang W
    Histopathology; 2013 Sep; 63(3):362-70. PubMed ID: 23758499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inactivation of PMS2 gene by promoter methylation in nasopharyngeal carcinoma].
    Ni HF; Jiang B; Zhou Z; Li Y; Yuan XY; Cao XL; Huang GW
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):812-817. PubMed ID: 27998438
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation between OPN gene polymorphisms and the risk of nasopharyngeal carcinoma.
    Wang JL; Nong LG; Tang YJ; Wei YS; Yang FL; Wang CF
    Med Oncol; 2014 Jul; 31(7):20. PubMed ID: 24913806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of Zinc-finger protein X-linked is associated with reduced E-cadherin expression and unfavorable prognosis in nasopharyngeal carcinoma.
    Li Y; Yan X; Yan L; Shan Z; Liu S; Chen X; Zou J; Zhang W; Jin Z
    Int J Clin Exp Pathol; 2015; 8(4):3919-27. PubMed ID: 26097576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.